Taofeek Owonikoko, MD, PhD, a clinician and researcher at Winship Cancer Institute of Emory University, has been selected to participate in the 2015-2016 American Society of Clinical Oncology (ASCO) Leadership Development Program. The ASCO Leadership Development Program, initially launched in 2009, is a year-long program designed to train future leaders in medicine by providing practicing oncologists with leadership skills training, networking opportunities, and mentorship from ASCO leaders.
Owonikoko, an associate professor in the Department of Hematology and Medical Oncology at the Emory School of Medicine, is one of sixteen participants selected for the program based on his leadership experience and commitment to making a difference in the oncology community.
Owonikoko's research interest is in the areas of lung and thyroid cancer. He focuses on the identification and clinical development of biomarkers and new treatment approaches to improve the standard of care for patients. "I am honored to have been selected for this prestigious program," says Owonikoko. "The ASCO Leadership Development Program is a valuable opportunity for formal leadership training that will enable me to give back and create change within ASCO, Winship Cancer Institute and the oncology community as a whole."
"ASCO is dedicated to cultivating the next generation of leaders in the oncology community," said ASCO CEO Allen S. Lichter, MD, FASCO. "This program is a valuable opportunity for participants to improve their skills and positively impact the future of cancer care."